期刊文献+

复方卡力孜然酊联合糠酸莫米松乳膏治疗白癜风的疗效观察 被引量:1

Efficacy observation on Compound Kaliziran Tincture combined with Mometasone Furoate Cream in the treatment of vitiligo
原文传递
导出
摘要 目的 观察复方卡力孜然酊联合0.1%糠酸莫米松乳膏治疗白癜风的临床疗效.方法 将120例白癜风患者随机分为两组,对照组54例外用0.1%糠酸莫米松乳膏治疗,治疗组66例在对照组治疗基础上联合复方卡力孜然酊治疗,两组均治疗3个月为1个疗程,疗程结束后评定疗效.结果 治疗组愈显率为60.94%,对照组为32.69%,两组愈显率比较,差异有统计学意义(χ2=7.86,P<0.05).结论 复方卡力孜然酊联合0.1%糠酸莫米松乳膏治疗白癜风疗效优于单用0.1%糠酸莫米松乳膏. Objective To observe the efficacy and safety of Compound Kaliziran Tincture combined with 0.1%Mometasone Furoate Cream in the treatment of vitiligo. Methods A total of 120 patients of vitiligo were randomly recruited into a control group (54 cases) and a treatment group (66 cases). The treatment group was treated with compound kaliziran tincture combined with 0.1% mometasone furoate cream for external use, while the control group was treated with topical 0.1% mometasone furoate cream. Both groups received the treatment for one course of three months. Efficacy was assessed at the end of the course. Results The total effective rate was 60.94% and 32.69% in the treatment group and the control group respectively, the difference showing statistical significance (χ2=7.86, P<0.05) . Conclusion It is safe and effective for compound kaliziran tincture combined with 0.1% mometasone furoate in the treatment of vitiligo with few side effects. The combined therapy is better than single using 0.1% mometasone furoate cream.
作者 李河山 李坤
出处 《国际中医中药杂志》 2010年第4期330-331,共2页 International Journal of Traditional Chinese Medicine
关键词 白癜风 复方卡力孜然酊 0.1%糠酸莫米松乳膏 Vitiligo Compound kaliziran tincture 0.1% mometasone furoate cream
  • 相关文献

参考文献10

二级参考文献28

  • 1吴纪园.两种卤米松乳膏治疗局限性白癜风临床疗效对比[J].临床皮肤科杂志,2005,34(2):97-97. 被引量:23
  • 2石得仁,刘昶时.白癜风患者发内微量元素测定及驱虫斑鸠菊治疗白癜风[J].中华皮肤科杂志,1989,22(5):326-327. 被引量:19
  • 3Wertz PW, Abraham W, Landmann L, et al. Preparation of liposomes from stratum corneum lipids [J]. J Invest Dermatol, 1986, 87 (5):582-584.
  • 4Ando H, Itoh A, Mishima Y, et al. Correlation between the number of melanosomes, tyrosinase mRNA levels, and tyrosinase activity in cultured murine melanoma cells in response to various melanogenesis regulatory agents[J]. J Cell Physiol, 1995, 163(3): 608-614.
  • 5Nakajima M, Shinoda I, Fukuwatari Y, et al. Arbutin increases the pigmentation of cultured human melanocytes through mechanisms other than the induction of tyrosinase activity[J]. Pigment Cell Res, 1998, 11(1): 12-17.
  • 6Danno K. PUVA therapy: current concerns in Japan[J]. J Dermatol Sci,1999, 19(2): 89-105.
  • 7Brown DA. Skin pigmentation enhancers[J]. J Photochem Photobiol B,2001, 63(1-3): 148-161.
  • 8Anthony FA, Laboda HM, Costlow ME. Psoralen-fatty acid adducts activate melanocyte protein kinase C: a proposed mechanism for melanogenesis induced by 8-methoxypsoralen and ultraviolet A light[J]. Photodermatol Photoimmunol Photomed, 1997, 13(1-2): 9-16.
  • 9Ben-Hur E, Moor AC, Margolis-Nunno H, et al. The photodecontamination of cellular blood components: mechanisms and use of photosensitization in transfusion medicine[J]. Transfus Med Rev, 1996,10(1): 15-22.
  • 10Krutmann J, Morita A. Mechanisms of ultraviolet (UV) B and UVA phototherapy[J]. J Investig Dermatol Symp Proc, 1999, 4(1): 70-72.

共引文献902

同被引文献32

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部